Replimune Group
REPL
REPL
140 hedge funds and large institutions have $594M invested in Replimune Group in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 52 increasing their positions, 32 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
39% less capital invested
Capital invested by funds: $971M → $594M (-$377M)
53% less call options, than puts
Call options by funds: $1.71M | Put options by funds: $3.67M
Holders
140
Holding in Top 10
3
Calls
$1.71M
Puts
$3.67M
Top Buyers
| 1 | +$71M | |
| 2 | +$41.9M | |
| 3 | +$23.1M | |
| 4 |
DM
Deerfield Management
New York
|
+$15.3M |
| 5 |
Goldman Sachs
New York
|
+$14.2M |
Top Sellers
| 1 | -$36.7M | |
| 2 | -$22.1M | |
| 3 | -$18.1M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$12.4M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$10.9M |